Mycobutin
- Product NDC
- 0013-5301
- 11-digit product format
- 000135301
- Labeler code
- 0013
- Product ID
- 0013-5301_47f0a676-c541-4d24-8710-bef6180556e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifabutin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA050689
- Marketing category
- NDA
- Marketing start
- 1992-12-23
- Marketing end
- 0000-00-00
- Substance
- RIFABUTIN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Rifamycin Antimycobacterial [EPC],Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| RIFABUTIN | ACTIVE INGREDIENT | 1W306TDA6S | MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| RIFABUTIN | ACTIVE MOIETY | 1W306TDA6S | MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| RIFABUTIN | ACTIVE INGREDIENT | 1W306TDA6S | MYCOBUTIN (RIFABUTIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| RIFABUTIN | ACTIVE MOIETY | 1W306TDA6S | MYCOBUTIN (RIFABUTIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | MYCOBUTIN (RIFABUTIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | MYCOBUTIN (RIFABUTIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MYCOBUTIN (RIFABUTIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | MYCOBUTIN (RIFABUTIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | MYCOBUTIN (RIFABUTIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | MYCOBUTIN (RIFABUTIN) CAPSULE [PHYSICIANS TOTAL CARE, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0013-5301 | MYCOBUTIN (RIFABUTIN) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 24 | Legacy NDC | 20241225_3e1a6613-bdd3-4261-93b3-d7f5cc09064b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0013-5301-17 | 00013530117 | 100 CAPSULE in 1 BOTTLE (0013-5301-17) | 100 capsule | 1992-12-23 | 0000-00-00 | No | No | Current |